---
id: sccm-sedation-icu-2024
title: "SCCM 2024 Clinical Practice Guidelines: Sedation, Analgesia, and Delirium in the ICU"
short_title: "SCCM Sedation ICU 2024"

organization: Society of Critical Care Medicine
collaborators: null
country: US
url: https://www.sccm.org/
doi: null
pmid: null
open_access: true

specialty: critical-care
guideline_type: clinical-practice
evidence_system: SCCM GRADE
conditions:
  - ICU sedation
  - delirium
  - agitation
  - pain management
tags:
  - propofol
  - dexmedetomidine
  - fentanyl
  - CAM-ICU
  - RASS

publication_date: 2024-02-01
previous_version_date: 2018-01-01
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-26
---

## Scope
2024 SCCM clinical practice guideline update on the management of pain, agitation, sedation, delirium, and immobility in critically ill adults (PADIS guidelines update).

## Key Recommendations

### Pain Assessment and Management
- **Assess Pain First**: Use validated tools (BPS, CPOT for non-verbal; NRS for verbal patients).
- **Analgesia-First Approach**: Treat pain before sedation.
- **Opioids (Fentanyl, Morphine, Hydromorphone)**: First-line for moderate-severe pain.
- **Non-Opioid Adjuncts**: Acetaminophen, NSAIDs (if not contraindicated), ketamine, regional anesthesia.

### Sedation

#### Goals
- Light sedation preferred (RASS 0 to -2) unless deep sedation required (ARDS, neuromuscular blockade, ICP management).
- Daily sedation interruption or targeted light sedation protocols.

#### Agents
- **Propofol**: First-line for general sedation; rapid onset/offset.
- **Dexmedetomidine (Precedex)**: Alpha-2 agonist. Favored when delirium is a concern or for facilitation of extubation. May reduce delirium vs. benzodiazepines.
- **Benzodiazepines (Midazolam, Lorazepam)**: Associated with increased delirium; avoid in most patients. Reserve for alcohol withdrawal, seizures, or refractory agitation.

### Delirium

#### Assessment
- Screen at least once per shift using CAM-ICU or ICDSC.

#### Prevention
- Optimize pain control, light sedation, early mobilization, sleep hygiene, cognitive engagement, minimize benzodiazepines, avoid anticholinergics.

#### Treatment
- Address underlying causes (infection, medications, hypoxia, metabolic derangements).
- Non-pharmacologic interventions first.
- **Antipsychotics (Haloperidol, Quetiapine)**: May be used for severe agitation/hyperactive delirium; no proven mortality benefit.

### Mobility
- Early mobilization and physical therapy for all appropriate ICU patients to reduce weakness and delirium.

### Sleep
- Promote sleep hygiene: Reduce noise/light, cluster care, minimize nocturnal interruptions.
